Terms: = Liver cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
49 results:
1. Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions.
Friemel J; Torres I; Brauneis E; Thörner T; Schäffer AA; Gertz EM; Grob T; Seidl K; Weber A; Ried T; Heselmeyer-Haddad K
Sci Rep; 2022 Dec; 12(1):22622. PubMed ID: 36587184
[TBL] [Abstract] [Full Text] [Related]
2. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract] [Full Text] [Related]
3. Relationship between Methylation of fhit and CDH13 Gene Promoter Region and liver cancer.
Tuoya AD; Wang DX; Xing YS; Liu RJ; Hu YX; Zhang MD; Bai TY; Lv XL; Li J; Chang FH
Curr Med Sci; 2020 Jun; 40(3):502-509. PubMed ID: 32474857
[TBL] [Abstract] [Full Text] [Related]
4. Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type.
Tian S; Li R; Wang T; Wang S; Tao R; Hu X; Ding H
Cancer Med; 2019 Jul; 8(7):3349-3358. PubMed ID: 31050212
[TBL] [Abstract] [Full Text] [Related]
5. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.
Sepulveda JL; Komissarova EV; Kongkarnka S; Friedman RA; Davison JM; Levy B; Bryk D; Jobanputra V; Del Portillo A; Falk GW; Sonett JR; Lightdale CJ; Abrams JA; Wang TC; Sepulveda AR
Int J Cancer; 2019 Nov; 145(10):2754-2766. PubMed ID: 31001805
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of Relationship between Occurrence of liver cancer and Methylation of Fragile Histidine Triad (fhit) and P16 Genes.
Bai Y; Shen Y; Yuan Q; Lv C; Xing Q
Med Sci Monit; 2019 Feb; 25():1301-1306. PubMed ID: 30773529
[TBL] [Abstract] [Full Text] [Related]
7. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
[TBL] [Abstract] [Full Text] [Related]
8. In silico analysis of fragile histidine triad involved in regression of carcinoma.
Rasheed MA; Tariq F; Afzal S; Mannanv S
J Pak Med Assoc; 2017 Apr; 67(4):616-621. PubMed ID: 28420927
[TBL] [Abstract] [Full Text] [Related]
9. Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before liver Transplantation.
Alotaibi F; Kabbani M; Abaalkhail F; Chorley A; Elbeshbeshy H; Al-Hamoudi W; Alabbad S; Boehnert MU; Alsofayan M; Al-Kattan W; Ahmed B; Broering D; Al Sebayel M; Elsiesy H
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):37-41. PubMed ID: 28260429
[TBL] [Abstract] [Full Text] [Related]
10. Expression and Prognostic Role of fhit, Fibronectin, and PTEN in Hepatocellular Carcinoma.
Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
[TBL] [Abstract] [Full Text] [Related]
11. Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The cancer Genome Atlas data.
Kim IW; Han N; Kim MG; Kim T; Oh JM
Pharmacogenet Genomics; 2015 Jan; 25(1):1-7. PubMed ID: 25379720
[TBL] [Abstract] [Full Text] [Related]
12. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients.
Kim SK; Kim SY; Kim JH; Roh SA; Cho DH; Kim YS; Kim JC
Mol Oncol; 2014 Dec; 8(8):1653-66. PubMed ID: 25049118
[TBL] [Abstract] [Full Text] [Related]
13. Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing.
Jiang JH; Liu YF; Ke AW; Gu FM; Yu Y; Dai Z; Gao Q; Shi GM; Liao BY; Xie YH; Fan J; Huang XW; Zhou J
Hepatology; 2014 Jun; 59(6):2216-27. PubMed ID: 24425307
[TBL] [Abstract] [Full Text] [Related]
14. [Incidence and mortality of cancer in Zhejiang province in 2009].
Li HZ; Mao WM; Wang XH; Yu CD; Du LB
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jul; 47(7):592-6. PubMed ID: 24304949
[TBL] [Abstract] [Full Text] [Related]
15. Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.
Zhang X; Li HM; Liu Z; Zhou G; Zhang Q; Zhang T; Zhang J; Zhang C
J Gastroenterol; 2013 Jan; 48(1):132-43. PubMed ID: 22766745
[TBL] [Abstract] [Full Text] [Related]
16. HIV-TAT-fused fhit protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells.
Yu GR; Qin WW; Li JP; Hua W; Meng YL; Chen R; Yan B; Wang L; Zhang X; Jia LT; Zhao J; Zhang R; Yang AG
Biosci Rep; 2012 Jun; 32(3):271-9. PubMed ID: 21679157
[TBL] [Abstract] [Full Text] [Related]
17. Genome profiling of pancreatic adenocarcinoma.
Birnbaum DJ; Adélaïde J; Mamessier E; Finetti P; Lagarde A; Monges G; Viret F; Gonçalvès A; Turrini O; Delpero JR; Iovanna J; Giovannini M; Birnbaum D; Chaffanet M
Genes Chromosomes Cancer; 2011 Jun; 50(6):456-65. PubMed ID: 21412932
[TBL] [Abstract] [Full Text] [Related]
18. Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules.
Körner A; Mudduluru G; Manegold C; Allgayer H
Br J Cancer; 2010 Sep; 103(6):802-11. PubMed ID: 20736951
[TBL] [Abstract] [Full Text] [Related]
19. [The relationship between fhit and WWOX expression and clinicopathological features in hepatocellular carcinoma].
Lin J; Wang B; Huang AM; Wang XJ
Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):357-60. PubMed ID: 20510001
[TBL] [Abstract] [Full Text] [Related]
20. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma.
Loyo M; Brait M; Kim MS; Ostrow KL; Jie CC; Chuang AY; Califano JA; Liégeois NJ; Begum S; Westra WH; Hoque MO; Tao Q; Sidransky D
Int J Cancer; 2011 Mar; 128(6):1393-403. PubMed ID: 20473931
[TBL] [Abstract] [Full Text] [Related]
[Next]
